NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living >5 years following diagnosis. The NCCN Guidelines for Ovarian Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with ovarian, fallopian tube, and primary peritoneal cancers. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised guidance on alternative chemotherapy regimens for patients with advanced age and/or comorbidities, a new algorithm for recurrent low-grade serous carcinoma based on developing research and novel therapeutic agents, and updated language regarding tumor molecular analysis applications in ovarian cancer.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Natl Compr Canc Netw

Title: Journal of the National Comprehensive Cancer Network : JNCCN

Publisher: Harborside Press, LLC

ISSN (Electronic): 1540-1413

ISSN (Print): 1540-1405

Publication date (Electronic): September 2022

Volume: 20

Issue: 9

Affiliations

[1 ] The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

[2 ] Vanderbilt-Ingram Cancer Center.

[3 ] The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

[4 ] Mayo Clinic Cancer Center.

[5 ] University of Wisconsin Carbone Cancer Center.

[6 ] University of Colorado Cancer Center.

[7 ] Duke Cancer Institute.

[8 ] UCSF Helen Diller Family Comprehensive Cancer Center.

[9 ] Memorial Sloan Kettering Cancer Center.

[10 ] City of Hope National Medical Center.

[11 ] Patient advocate.

[12 ] Massachusetts General Hospital Cancer Center.

[13 ] The University of Texas MD Anderson Cancer Center.

[14 ] University of Washington/Seattle Cancer Care Alliance.

[15 ] Moffitt Cancer Center.

[16 ] Fox Chase Cancer Center.

[17 ] Stanford Cancer Institute.

[18 ] UCLA Jonsson Comprehensive Cancer Center.

[19 ] O'Neal Comprehensive Cancer Center at UAB.

[20 ] UC Davis Comprehensive Cancer Center.

[21 ] Dana-Farber/Brigham and Women's Cancer Center.

[22 ] Abramson Cancer Center at the University of Pennsylvania.

[23 ] Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

[24 ] UC San Diego Moores Cancer Center.

[25 ] University of Michigan Rogel Cancer Center.

[26 ] UT Southwestern Simmons Comprehensive Cancer Center.

[27 ] Fred & Pamela Buffett Cancer Center.

[28 ] St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

[29 ] Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

[30 ] Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

[31 ] Huntsman Cancer Institute at the University of Utah.

[32 ] Roswell Park Comprehensive Cancer Center; and.

[33 ] National Comprehensive Cancer Network.

Article

Publisher Item ID: jnccn2009glins

DOI: 10.6004/jnccn.2022.0047

PubMed ID: 36075393

SO-VID: 187674bb-4d31-4b1a-b620-b94b3aed19fa

History

Data availability:

Comments

Comment on this article

scite_

Cited by 58

See all cited by